Table 1.
Association between survivin expression and clinical data in ALL patients
Clinical data | Number | Survivin | χ2 | |
---|---|---|---|---|
+ ve (%) | −ve (%) | P-value | ||
Age | ||||
≤10 years | 22 | 12 (54.5) | 10 (45.5) | 2.743 |
≥10 years | 8 | 7 (87.5) | 1(12.5) | NS |
Sex | ||||
Male | 20 | 12 (60) | 8 (40) | 0.287 |
Female | 10 | 7 (70) | 3 (30) | NS |
Pallor | ||||
+ve | 25 | 15 (60) | 10 (40) | 0.717 |
−ve | 5 | 4 (75) | 1 (25) | NS |
Fever | ||||
+ve | 24 | 15 (62.5) | 9 (37.5) | 0.035 |
−ve | 6 | 4 (66.7) | 2 (33.3) | NS |
Bleeding tendancy | ||||
+ve | 23 | 14 (60.8) | 9 (39.2) | 0.257 |
−ve | 7 | 5 (71.4) | 2 (28.6) | NS |
Lymph nodes | ||||
+ve | 21 | 11 (52.4) | 10 (47.6) | 3.615 |
−ve | 9 | 8 (88.9) | 1 (11.1) | NS |
Hepatosplenomegaly | ||||
+ve | 22 | 14 (63.3) | 8 (36.4) | 0.003 |
−ve | 8 | 5 (62.5) | 3 (37.5) | NS |
CNS manifestation | ||||
+ve | 1 | 0 (0) | 1 (100) | 1.786 |
−ve | 29 | 19 (65.5) | 10 (34.5) | NS |
+ ve despin sign | ||||
+ve | 2 | 1 (50) | 1 (50) | 0.164 |
−ve | 28 | 18 (64.3) | 10 (35.7) | NS |
NS not significant